Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayDec 10, 2019 6:00 pm

U.S. Nuclear Corp. (UCLE) Starts Presentation at 12th Annual LD Micro Main Event

US Nuclear’s (OTCQB: UCLE) operations are principally engaged through its subsidiaries, operating two leading nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. The company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. Military, Homeland Security, Scientific Laboratories, Universities, Hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia, and others. For more information,…

Continue Reading

TuesdayDec 10, 2019 6:00 pm

LightPath Technologies Inc. (NASDAQ: LPTH) Starts Presentation at 12th Annual LD Micro Main Event

LightPath Technologies (NASDAQ: LPTH) is a global, vertically integrated provider of optics, photonics and infrared solutions for the industrial, commercial, defense, telecommunications and medical industries. LightPath designs, manufactures and distributes proprietary optical and infrared components including molded glass aspheric lenses and assemblies, infrared lenses and thermal imaging assemblies, fused fiber collimators, and proprietary Black DiamondTM (“BD6”) chalcogenide-based glass lenses. LightPath also offers custom optical assemblies, including full engineering design support. The company is headquartered in Orlando, Florida, with manufacturing and sales offices in Latvia and China. For more information, visit the company’s website at www.lightpath.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

Continue Reading

TuesdayDec 10, 2019 6:00 pm

BioLargo Inc. (BLGO) Starts Presentation at 12th Annual LD Micro Main Event

BioLargo (OTCQB: BLGO) invents, patents and develops innovative platform technologies for three markets: advanced water and wastewater treatment, industrial odor and VOC control, and advanced wound care products. With a wide array of issued patents, an extensive R&D talent pool, and a full-service engineering team, the company maintains a robust pipeline of products from inception through maturity.  BioLargo monetizes its technology assets with the goal of maximizing both impact and shareholder value, using licensing, strategic partnership, and direct-to-market strategies. For more information, visit the company’s website at www.biolargo.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access…

Continue Reading

TuesdayDec 10, 2019 5:40 pm

DelMar Pharmaceuticals Inc. (NASDAQ: DMPI) Starts Presentation at 12th Annual LD Micro Main Event

DelMar Pharmaceuticals (NASDAQ: DMPI) is a biopharmaceutical company focused on the development and commercialization of new cancer therapies. The company’s lead product candidate, VAL-083, is a "first-in-class" small molecule DNA-targeting agent that is currently being evaluated in a biomarker-driven, Phase 2 clinical trial for the treatment of Unmethylated MGMT recurrent glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. The company is also exploring VAL-083 in a Phase 2 trial as a therapy for front-line Unmethylated MGMT GBM and we may study other solid tumors, including ovarian cancer and pediatric CNS tumors. For more information, visit the…

Continue Reading

TuesdayDec 10, 2019 5:40 pm

Novus Therapeutics Inc. (NASDAQ: NVUS) Starts Presentation at 12th Annual LD Micro Main Event

Novus Therapeutics (NASDAQ: NVUS) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose and throat (“ENT”). Novus has two technologies, each that has the potential to be developed for multiple ENT indications. Novus’ lead product candidate (OP0201) is being developed as a potential first-in-class treatment option for patients at risk for, or with, otitis media (“OM”) or middle ear inflammation with or without infection. OM is one of the most common disorders seen in pediatric practice, and in the U.S. it is a leading cause of health care visits; and the most…

Continue Reading

TuesdayDec 10, 2019 5:40 pm

Artelo Biosciences Inc. (NASDAQ: ARTL) Starts Presentation at 12th Annual LD Micro Main Event

Artelo Biosciences (NASDAQ: ARTL) is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. The company’s programs have the potential to dramatically improve patient care in major markets. Artelo’s science-based approach rests on three pillars that uniquely position the company for growth: an unwavering dedication to letting the science lead; a portfolio-based, de-risked and nimble business strategy; and an experienced leadership team with proven performance in regulated drug development and global commercialization. For more information, visit…

Continue Reading

TuesdayDec 10, 2019 5:40 pm

Wow! Unlimited Media Inc. (TSXV: WOW) (WOWMF) Starts Presentation at 12th Annual LD Micro Main Event

WOW! Unlimited Media (TSXV: WOW) (OTCQX: WOWMF), is creating an animation-focused, multi-platform entertainment company by producing top-end content, and building brands and audiences on the most engaging media platforms. The company produces animation in its two established studios: Frederator Studios in Los Angeles, which has a 20-year track record; and Mainframe Studios in Vancouver, one of Canada's largest, multi-faceted animation production studios, which has a 25-year track record. The company’s media assets include Channel Frederator Network on YouTube, as well as WOW! branded programming on Crave, Canada’s leading streaming entertainment platform, owned by Bell Media. The company operates out of…

Continue Reading

TuesdayDec 10, 2019 5:40 pm

MRI Interventions Inc. (NYSE: MRIC) Starts Presentation at 12th Annual LD Micro Main Event

MRI Interventions (NYSE: MRIC) is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI guidance. Since its inception in 1998, the company has focused on research and product development in the field of interventional MRI. From 1998 to 2002, MRI deployed significant resources to fund efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, the company’s focus shifted to identifying and building out commercial applications for the technologies MRI developed…

Continue Reading

TuesdayDec 10, 2019 5:20 pm

Profire Energy Inc. (NASDAQ: PFIE) Starts Presentation at 12th Annual LD Micro Main Event

Profire Energy (NASDAQ: PFIE) assists energy production companies in the safe and efficient production and transportation of oil and natural gas. As energy companies seek greater safety for their employees, compliance with more stringent regulatory standards, and enhanced margins with their energy production processes, Profire Energy's burner management and chemical injection products are continuing to be a key part of their solutions. Profire Energy has offices in Lindon, Utah; Victoria, Texas; Homer, Pennsylvania; Greeley, Colorado; Millersburg, Ohio; and Spruce Grove, Alberta, Canada. For more information, visit the company’s website at www.profireenergy.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

Continue Reading

TuesdayDec 10, 2019 5:20 pm

Avalon GloboCare Corp. (NASDAQ: AVCO) Starts Presentation at 12th Annual LD Micro Main Event

Avalon GloboCare (NASDAQ: AVCO) is a global intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology and their clinical applications, as well as healthcare facility management through its core platforms, "Avalon Cell" and "Avalon Rehab." In addition, Avalon provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth, development, as well as competitiveness in both domestic and global healthcare markets. Avalon, via its subsidiary “Avalon RT9 Properties LLC,”also engages in the acquirement and management of healthcare facility. For more information, visit the company’s website at www.avalon-globocare.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000